James Wentworth
Corporate Officer/Principal bei TRANSGENE
Aktive Positionen von James Wentworth
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TRANSGENE | Corporate Officer/Principal | 22.01.2024 | - |
Karriereverlauf von James Wentworth
Ehemalige bekannte Positionen von James Wentworth
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - | - |
Ausbildung von James Wentworth
| University of Bristol | Doctorate Degree |
| International Institute for Management Development | Masters Business Admin |
Statistik
International
| Vereinigtes Königreich | 3 |
| Frankreich | 2 |
| Schweiz | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TRANSGENE | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Adaptimmune Ltd.
Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Health Services |
- Börse
- Insiders
- James Wentworth
- Erfahrung
